As a founder, Dr. Jolieke G. van Oosterwijk has extensive experience in drug and vaccine development, in the human and animal health space. Her work translating innovation to commercialization has led to a wide experience in writing research protocols, IACUCs, IBCs, clinical trials protocols, RFPs, and grant applications, managing CROs for clinical trials, C(D)MOs for scaling, masterseed, and production. Dr. van Oosterwijk has regulatory experience with the USDA and FDA focusing on innovative products and their pathway through regulatory frameworks by working together with the regulatory agencies to ensure a smooth road to licensing. Dr. van Oosterwijk leads the innovation of tomorrow as the vice chair of the Biomedical Engineering advisory board at the University of Memphis. Dr. van Oosterwijk has 27 publications and seven patents.

As a founder, Dr. Russell John Brooke has more than 15 years experience working with government agencies in human, animal, and environmental health spaces. His regulatory experience with the USDA and FDA covers licensing of novel technologies, drafting industry responses to agencies Request For Information, and government auditing. His career covers developing regulatory go to market strategies, compliance frameworks, data governance, pharmacogenomic bioinformatics, dose-response modeling, and biodefense. He has 19 publications, three patents, and two invention disclosures.